|
|
||||||||
Published online before print October 2, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Institute of Infection, Immunity and Inflammation and Division of Gastroenterology, University of Nottingham, United Kingdom
@ To whom correspondence should be addressed. E-mail: Yash.Mahida{at} Nottingham.ac.uk.
| Abstract |
|---|
The gastrointestinal (GI) tract is exposed to a wide range of microorganisms. The expression of antimicrobial peptides has been demonstrated in different regions of the GI tract, predominantly in epithelial cells, which represent the first host cells with which the microorganisms have to interact for invasion. The intestinal epithelial monolayer is complex, consisting of different cell types, and most have a limited lifespan. Of the GI antimicrobial peptides,
- and
-defensins have been studied the most and are expressed by distinct types of epithelial cells. Enteric
-defensin expression is normally restricted to Paneth and intermediate cells in the small intestine. However, there are important differences between mice and humans in the processing of the precursor forms of enteric
-defensins. Parasite infection induces an increase in the number of enteric
-defensin-expressing Paneth and intermediate cells in the murine small intestine. In the chronically inflamed colonic mucosa, metaplastic Paneth cells (which are absent in the normal colon) also express enteric
-defensins. Epithelial expression of
-defensins may be constitutive or inducible by infectious and inflammatory stimuli. The production of some members of the
-defensin family appears to be restricted to distinct parts of the GI tract. Recent studies using genetically manipulated rodents have demonstrated the likely in vivo importance of enteric antimicrobial peptides in innate host defense against microorganisms. The ability of these peptides to act as chemoattractants for cells of the innate- and adaptive-immune system may also play an important role in perpetuating chronic inflammation in the GI tract.
Key Words: epithelial cells defensins Paneth cells cryptdin
This article has been cited by other articles:
![]() |
A. S. Dugan, M. S. Maginnis, J. A. Jordan, M. L. Gasparovic, K. Manley, R. Page, G. Williams, E. Porter, B. A. O'Hara, and W. J. Atwood Human {alpha}-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells J. Biol. Chem., November 7, 2008; 283(45): 31125 - 31132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nuding, K. Fellermann, J. Wehkamp, and E. F Stange Reduced mucosal antimicrobial activity in Crohn's disease of the colon Gut, September 1, 2007; 56(9): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sundbom, D A Elphick, Y R Mahida, R N Cunliffe, T Midtvedt, L Engstrand, C Rubio, and L G. Axelsson Alteration in human defensin-5 expression following gastric bypass surgery J. Clin. Pathol., September 1, 2007; 60(9): 1029 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Elphick and Y R Mahida Paneth cells: their role in innate immunity and inflammatory disease Gut, December 1, 2005; 54(12): 1802 - 1809. [Full Text] [PDF] |
||||
![]() |
B Shen, E M Porter, E Reynoso, C Shen, D Ghosh, J T Connor, J Drazba, H K Rho, T L Gramlich, R Li, et al. Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract J. Clin. Pathol., July 1, 2005; 58(7): 687 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. van Wetering, G. S. Tjabringa, and P. S. Hiemstra Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells J. Leukoc. Biol., April 1, 2005; 77(4): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C Grimm and P Pavli NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link? Gut, November 1, 2004; 53(11): 1558 - 1560. [Full Text] [PDF] |
||||
![]() |
O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |